Description
The study demonstrates that FGF21 upregulates SIRT1, which then deacetylates FOXO3 to enhance mitophagy, but the direct molecular mechanism by which FGF21 increases SIRT1 levels is not explained. Understanding this upstream regulatory mechanism is crucial for developing targeted therapeutic interventions.
Gap type: unexplained_observation Source paper: FGF21-Mediated Upregulation of SIRT1 Delays Intervertebral Disc Degeneration by Promoting PINK1/Parkin Dependent Mitophagy Through Deacetylation of FOXO3. (2026, Aging Cell, PMID:41860561)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:33.696654+00:00”, “resolution_summary”: “Resolved by hypothesis h-53fd55dc89: FOXO3-Pioneer Factor Complex Stabilizes Heterochromatin Under Oxidative Stress. Supporting evidence includes debate sess_SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2_20260416-033018.”, “match_counts”: {“hypothesis_matches”: 5, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-53fd55dc89”, “title”: “FOXO3-Pioneer Factor Complex Stabilizes Heterochromatin Under Oxidative Stress”, “score”: 0.356, “reason”: “20 token overlaps; entity overlap: foxo3, sirt1”, “analysis_id”: “SDA-2026-04-10-gap-20260410-091440”, “target_gene”: “FOXO3; SIRT1”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.7, “confidence_score”: 0.7, “status”: “proposed”, “pubmed_evidence_ids”: [“15814714”, “16814721”, “24431302”, “30661960”, “34890308”]}, {“id”: “h-metrep-b3a540aad7e8”, “title”: “Caloric Restriction Mimetic Combination Therapy (Metformin + Resveratrol + Rapamycin) Achieves Synergistic Neuronal Longevity via Coordinated AMPK-SIRT1-mTOR Axis Activation”, “score”: 0.346, “reason”: “9 token overlaps; entity overlap: foxo3, sirt1”, “analysis_id”: null, “target_gene”: “AMPK,PRKAA1,PRKAA2,SIRT1,MTOR,RPTOR,PPARGC1A,FOXO3,FOLH1”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.64, “confidence_score”: 0.75, “status”: “proposed”, “pubmed_evidence_ids”: [“27034026”, “28622524”, “28723898”, “33862221”, “34547233”]}, {“id”: “h-da9af6a77a”, “title”: “NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic Axis and Dopaminergic Neuron Survival in Parkinson’s Disease Models”, “score”: 0.331, “reason”: “19 token overlaps; entity overlap: foxo3, sirt1”, “analysis_id”: “SDA-2026-04-04-gap-20260404-060512”, “target_gene”: “SIRT1/NAD+ axis”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.79, “confidence_score”: 0.73, “status”: “proposed”, “pubmed_evidence_ids”: [“26997585”, “31182973”, “31577933”, “35879466”, “36224412”]}, {“id”: “h-827a821b”, “title”: “Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Circuits”, “score”: 0.331, “reason”: “21 token overlaps; entity overlap: foxo3, sirt1”, “analysis_id”: “SDA-2026-04-03-gap-crispr-neurodegeneration-20260402”, “target_gene”: “PGC1A, SIRT1, FOXO3, mitochondrial biogenesis genes”, “target_pathway”: “PGC1α/SIRT1/FOXO3 mitochondrial biogenesis network”, “disease”: “neurodegeneration”, “composite_score”: 0.59874, “confidence_score”: 0.4, “status”: “proposed”, “pubmed_evidence_ids”: [“32470790”, “37267686”, “37705748”, “41743852”]}, {“id”: “h-7c3c0f40”, “title”: “Epigenetic Memory Reprogramming via CRISPRa-Mediated Chromatin Remodeling”, “score”: 0.319, “reason”: “16 token overlaps; entity overlap: foxo3, sirt1”, “analysis_id”: “SDA-2026-04-03-gap-crispr-neurodegeneration-20260402”, “target_gene”: “SIRT1, FOXO3, NRF2, TFAM”, “target_pathway”: “Sirtuin-1 / NAD+ metabolism / deacetylation”, “disease”: “neurodegeneration”, “composite_score”: 0.5445, “confidence_score”: 0.5, “status”: “proposed”, “pubmed_evidence_ids”: []}], “debate_matches”: [{“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2_20260416-033018”, “title”: “The abstract shows p53 is a central regulator of C9orf72-mediated neurodegeneration but doesn’t explain how poly(PR) specifically activates p53. Understanding this upstream trigger mechanism is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). (None, None, PMID:33482083)”, “score”: 0.486, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-083737-59771b32_20260416-033540”, “title”: “The study demonstrates that SGMS1 elevation correlates with increased Aβ and that SGMS inhibition reduces Aβ production, but the specific biochemical pathways connecting sphingomyelin metabolism to APP processing remain unexplained. Understanding this mechanism is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: Elevation in sphingomyelin synthase activity is associated with increases in amyloid-beta peptide generation. (None, None, PMID:23977395)”, “score”: 0.468, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-083737-59771b32”, “quality_score”: 0.75, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062150-387cb0ba_task_9aae8fc5”, “title”: “While the study establishes that trehalose-induced lysosomal permeabilization activates calcium-dependent calcineurin leading to TFEB activation, the molecular basis for this specific signaling cascade is not explained. Understanding this specificity is crucial for developing targeted autophagy modulators.\n\nGap type: unexplained_observation\nSource paper: Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. (2019, Autophagy, PMID:30335591)”, “score”: 0.468, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062150-387cb0ba”, “quality_score”: 0.731, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0_task_9aae8fc5”, “title”: “The abstract mentions that pathological seeds have different characteristics and conformations, but the underlying molecular mechanisms that generate this diversity remain unclear. Understanding these mechanisms is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: Protein transmission in neurodegenerative disease. (2020, Nat Rev Neurol, PMID:32203399)”, “score”: 0.458, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.43, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}